Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page
- Check6 days agoChange DetectedThe record indicates the study is no longer recruiting participants, marking a halt in enrollment. A new revision entry (v3.6.0) has been added to the history, replacing the prior revision (v3.5.5).SummaryDifference0.2%

- Check13 days agoChange DetectedThe record history now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a new version of the page’s history. This update is a metadata/versioning change rather than a modification to trial data or content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe record history shows a new revision label, Revision: v3.5.4, replacing the previous v3.5.3. This reflects a metadata update to the page’s revision history rather than changes to the study content or results.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a minor update to the ClinicalTrials.gov interface/version rather than a study data change.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the history. The change appears to be a system or UI update rather than content changes to the study records.SummaryDifference0.1%

- Check92 days agoChange Detected- Added revision v3.5.0 to the Study Record Versions. - Removed revision v3.4.3 from history.SummaryDifference0.1%

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.